Navigation Links
Thomas, McNerney & Partners Promotes Three Members of Its Investment Team
Date:1/8/2009

Kathy Tune Promoted to Principal. Christine Siu and Jason Brown, Ph.D. Promoted to Vice President

MINNEAPOLIS, SAN FRANCISCO and STAMFORD, Conn., Jan. 8 /PRNewswire/ -- Thomas, McNerney & Partners, a health care venture capital firm that invests in life science and medical technology companies, today announced the promotion of three members of its investment team. Kathy Tune has been promoted to Principal. Christine Siu and Jason Brown have been promoted to Vice President.

"We are pleased to announce the promotion of these three valuable members of our investment staff," said James Thomas, Partner. "Each of these individuals has made important contributions to the firm and these promotions recognize both their development as professionals and the growth and maturity of the firm and its investment team."

Kathy Tune joined the firm's Minneapolis office in 2003 and focuses her investment practice on the medical device sector. Kathy was previously with Piper Jaffray and Solvay. Kathy is a board member of Softscope Medical Technologies, Inc. Her educational background includes an M.S. degree in Microbiology from the University of Minnesota and an M.B.A. from the University of Minnesota's Carlson School of Management, where she was a Robert and Gail Buuck Scholar.

Christine Siu joined the firm's Connecticut office in 2005 and focuses her investment activities on venture opportunities in the public and late-stage private markets. Prior to Thomas, McNerney, Christine was at Warburg Pincus and Bear Stearns. Christine is a graduate of the University of Michigan with a B.S. with distinction in Cellular Molecular Biology and Economics and holds an M.B.A. from Harvard Business School.

Jason Brown joined Thomas, McNerney's San Francisco office in 2007 and focuses his investment practice in the biopharmaceutical sector. Jason previously spent four years at Forward Ventures and conducted research in antimicrobial drug discovery and bacterial genomics as a postdoctoral fellow in Infectious Diseases at Johnson & Johnson Pharmaceutical Research and Development. He is currently a board member of Altair Therapeutics, Inc. Jason earned a Ph.D. in Biology at the University of California, San Diego, where he was a National Science Foundation Fellow, and a B.S. in Molecular Biology and Biochemistry from Purdue University.

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early-stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies, as well as recapitalizations. The firm is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. The firm has offices in Stamford, Minneapolis and San Francisco.

For further information, please visit www.tm-partners.com.


'/>"/>
SOURCE Thomas, McNerney & Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
5. AtriCure to Present at Roth Capital Partners 2007 New York Conference
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. National Patient Safety Foundation Partners with Vocera Communications
11. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Lake Orion, Michigan (PRWEB) , ... March 27, ... ... loss results. The comprehensive weight management program at Women’s Excellence will help ... an initial evaluation and physical exam. The specialists at Women's Excellence will ...
(Date:3/27/2017)... Atlanta, Georgia (PRWEB) , ... March 27, 2017 ... ... pleased to announce that for a second year in a row; they are ... leading healthcare designers in the industry voted on the award at Design Connections ...
(Date:3/27/2017)... Angeles, CA (PRWEB) , ... March 27, 2017 , ... ... men with prostate cancer, including all stages, is more than 95%. Once the cancer ... drastically to less than 30%. To find out how to avoid this latter group, ...
(Date:3/27/2017)... Angel, Oregon (PRWEB) , ... March 27, 2017 ... ... company, is pleased to announce the launch of a months-long rebranding effort. This ... new formulations. , “Through focus group discussions and market research, we learned that ...
(Date:3/27/2017)... ... March 27, 2017 , ... From ... opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) ... (AB) 1512, which proposes a tax on prescription opioids to fund drug rehabilitation ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LEXINGTON, Mass. , March 27, 2017   Pulmatrix, ... innovative inhaled therapies to address serious pulmonary diseases, today announced ... allergic fungal disease, cystic fibrosis and asthma to its ... Richard B. Moss , MD, ... former Director of the Cystic Fibrosis Center at Stanford University, ...
(Date:3/27/2017)... , March 27, 2017  BERG, a ... data-driven, biological research approach, today announced that ... the discovery of new data using a ... brown fat metabolism. Joslin Diabetes Center led ... Biology® platform for analysis of samples.  The ...
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
Breaking Medicine Technology: